Who is
Visby Medical?

Watch our video to learn more about our mission and story.

Play Video

Our Story

Our journey began in 2010, when the earliest team members began to explore the idea of a diagnostic test that could be used by anyone, anywhere.

The concept

2010 - 2011

While completing an Entrepreneur-in-Residence at Artiman Ventures, Visby founder Adam de la Zerda explores the concept of a diagnostic so simple it could be used by anyone, anywhere.

Company founded


After researching the market and finding nothing significant, Adam incorporates Click Diagnostics in December. Soon after, Greg Loney joins as a founding executive and the VP of engineering.

Focusing on sexual health


Click Diagnostics explores a number of markets and identifies sexual health as the direction to pursue. Work begins on an STI test focused on women’s health.

First functional prototype


Click Diagnostics develops its first fully integrated device. Small enough to fit in the palm of your hand, the PCR test delivers rapid and accurate results.

FDA clinical study


NIH sponsors the FDA clinical study for the sexual health product.

Sexual Health Test - FDA submission


Click Diagnostics submits its package to the FDA for its sexual health test. By mid-March, the team decides to join the fight against a new SARS pathogen, COVID-19.

Name change


In March, Click Diagnostics officially becomes Visby Medical.

Visby Medical COVID-19 Test


By July, Visby Medical has a functional COVID-19 test. It receives its first authorization from the FDA in September.

Visby Medical Sexual Health Test


The Visby Medical Sexual Health Click Test receives FDA clearance and CLIA waiver, making it the first instrument-free PCR test for the detection of Chlamydia, Gonorrhea, and Trichomonas.